Bioventus (BVS) Return on Capital Employed Growth (1y) (2022 - 2026)
Bioventus (BVS) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 216.00 |
| 10 | Bioventus | 972.23 Mn | 942.77 Mn | 105.67 Mn | 470.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 470.00 |
| Mar 28, 2026 | 1,394.00 |
| Dec 31, 2025 | 1,296.00 |
| Sep 27, 2025 | 1,160.00 |
| Jun 28, 2025 | 1,082.00 |
| Mar 29, 2025 | -528.00 |
| Dec 31, 2024 | 1,004.00 |
| Sep 28, 2024 | 1,104.00 |
| Jun 29, 2024 | 2,926.00 |
| Mar 30, 2024 | 2,789.00 |
| Dec 31, 2023 | 261.00 |
| Sep 30, 2023 | 39.00 |
| Jul 1, 2023 | -3,046.00 |
| Apr 1, 2023 | -2,245.00 |
| Dec 31, 2022 | -1,705.00 |
| Oct 1, 2022 | -1,956.00 |
| Jul 2, 2022 | -886.00 |
| Apr 2, 2022 | -1,022.00 |